Why the study?
To address the current issues of radiation-induced cardiovascular complications, diagnostics, incidence related to radiation doses and exposure regimens, and screening strategies for cardiotoxicity monitoring in cancer patients.
This review summarizes current knowledge on radiation-induced cardiovascular complications, their diagnostics, and screening strategies for cardiotoxicity monitoring in cancer patients.
Guideline-based screening for radiation cardiotoxicity warrants consideration in cancer survivors; leaves open optimal regimen-specific protocols.
The review is devoted to the current issues of radiation-induced cardiovascular complications, their diagnostics andincidence depending on the radiation doses and exposure regimens, potential efficiency of the screening strategiesfor cardiotoxicity monitoring after radiotherapy in cancer patients by analyzing the data from literature and clinical trials, based on recommendations of European Society of Cardiology and European Society of Medical Oncology.
No takes yet. Share an insight, caveat, or question.
Kozhukhov et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: